However, some of these markers have limitations; for example, despite the high sensitivity of calprotectin and lactoferrin as markers of endoscopically active IBD [22], some patients may prefer blood-based over stool-based testing [19]. This evidence concerns the gene LTF and inflammatory bowel disease.